English
  1. Home
  2. Stocks
  3. Suven Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Suven Life Sciences Share Price Suven Life Sciences

    Small Cap
    ₹100.8
    +1.15 (1.15%)
    13 May, 2024 03:06 BSE: 530239 NSE: SUVENISIN: INE495B01038

    Start SIP in Suven Life Sciences

    Start SIP

    Suven Life Sciences Performance

    Day Range

    • Low 98
    • High 102
    ₹ 100

    52 Week Range

    • Low 55
    • High 129
    ₹ 100
    • Open Price101
    • Previous Close100
    • Volume141756

    Suven Life Sciences Share Price

    • Over 1 Month -13.55%
    • Over 3 Month -8.15%
    • Over 6 Month +17.35%
    • Over 1 Year +70.56%

    Suven Life Sciences Key Statistics

    P/E Ratio -20.9
    PEG Ratio -1.9
    Market Cap Cr 2,198
    Price to Book Ratio 8.1
    EPS -0.7
    Dividend 0
    Relative Strength Index 38.38
    Money Flow Index 52.77
    MACD Signal 0.53
    Average True Range 5.14
    Suven Life Sciences Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 22343
    Operating Expenses Qtr Cr 91211119
    Operating Profit Qtr Cr -7-9-8-7-6
    Depreciation Qtr Cr 22222
    Interest Qtr Cr 00000
    Tax Qtr Cr -10000
    Net Profit Qtr Cr -3-53-3-2
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 3322
    Operating Expenses Annual Cr 4341
    Operating Profit Annual in Cr -31-28
    Depreciation Cr 77
    Interest Annual Cr 00
    Tax Annual Cr -10
    Net Profit Annual Cr -8-20
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 12-10
    Cash from Investing Activity Annual Cr -34-362
    Cash from Financing Annual Activity Cr -1396
    Net Cash Flow Annual Cr 24
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 845853
    Fixed Assets Annual Cr 2837
    Total Non Current Assets Annual Cr 605619
    Total Current Assets Annual Cr 246241
    Total Assets Annual Cr 851860
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 3939
    ROE Annual % -1-2
    ROCE Annual % -2-3
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % -84-143
    Sign Up to Know More
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 22343
    Operating Expenses Qtr Cr 3349273234
    Operating Profit Qtr Cr -30-46-24-28-32
    Depreciation Qtr Cr 22222
    Interest Qtr Cr 00000
    Tax Qtr Cr -10000
    Net Profit Qtr Cr -27-42-13-24-28
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 3322
    Operating Expenses Annual Cr 140139
    Operating Profit Annual in Cr -128-126
    Depreciation Cr 77
    Interest Annual Cr 00
    Tax Annual Cr -10
    Net Profit Annual Cr -105-118
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -83-103
    Cash from Investing Activity Annual Cr 62-261
    Cash from Financing Annual Activity Cr -1396
    Net Cash Flow Annual Cr 32
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 270375
    Fixed Assets Annual Cr 2837
    Total Non Current Assets Annual Cr 28137
    Total Current Assets Annual Cr 257252
    Total Assets Annual Cr 285389
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 1217
    ROE Annual % -39-32
    ROCE Annual % -42-33
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % -914-867
    Sign Up to Know More
    Invest in Suven Life Sciences

    Suven Life Sciences Technicals

    EMA & SMA

    Current Price
    ₹100.8
    +1.15 (1.15%)
    pointer
    • Bullish Moving Average
    • ___
    • 3
    • Bearish Moving Average
    • ___
    • 13
    • 20 Day
    • ₹107.82
    • 50 Day
    • ₹106.91
    • 100 Day
    • ₹102.05
    • 200 Day
    • ₹92.46
    • 20 Day
    • ₹109.62
    • 50 Day
    • ₹106.68
    • 100 Day
    • ₹104.19
    • 200 Day
    • ₹88.41

    Suven Life Sciences Resistance and Support

    PIVOT
    ₹100.17
    Resistance
    First Resistance 102.63
    Second Resistance 104.47
    Third Resistance 106.93
    RSI 38.38
    MFI 52.77
    MACD Single Line 0.53
    MACD -0.93
    Support
    First Resistance 98.33
    Second Resistance 95.87
    Third Resistance 94.03

    Suven Life Sciences Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 160,199 9,951,562 62.12
    Week 203,451 14,379,931 70.68
    1 Month 248,758 19,823,521 79.69
    6 Month 735,491 39,334,082 53.48

    Suven Life Sciences Result Highlights

    Suven Life Sciences Synopsis

    NSE-Medical-Diversified

    Suven Life Sciences is involved in the business activities of Other professional, scientific and technical activities. Company’s Total Operating Revenue is Rs. 13.54 Cr. and Equity Capital is Rs. 21.81 Cr. for the Year ended 31/03/2023. Suven Life Sciences Ltd. is a Public Limited Listed company incorporated on 09/03/1989 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110TG1989PLC009713 and registration number is 009713.
    Market Cap 2,198
    Sales 12
    Shares in Float 6.54
    No of funds 15
    Yield 0.89
    Book Value 2.6
    U/D Vol ratio 1.3
    LTDebt / Equity
    Alpha 0.17
    Beta 1.15

    Suven Life Sciences

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 69.57%69.57%69.57%69.57%
    Mutual Funds 1.05%0.01%0.01%0.01%
    Foreign Portfolio Investors 0.46%0.54%0.5%0.48%
    Financial Institutions/ Banks
    Individual Investors 22.3%24.05%24.38%23.29%
    Others 6.62%5.83%5.54%6.65%

    Suven Life Sciences Management

    Name Designation
    Mr. Venkateswarlu Jasti Chairman & CEO
    Mrs. Sudharani Jasti Whole Time Director
    Mrs. J A S Padmaja Director
    Prof. Seyed E Hasnain Director
    Mr. M Gopalakrishna Director
    Mr. Santanu Mukherjee Director

    Suven Life Sciences Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Suven Life Sciences Corporate Action

    Date Purpose Remarks
    2024-05-06 Audited Results
    2024-01-30 Quarterly Results
    2023-11-04 Quarterly Results
    2023-08-08 Quarterly Results
    2023-05-09 Audited Results

    Suven Life Sciences MF Shareholding

    Name Amount(cr)
    Quant Business Cycle Fund Regular Growth 1,111
    Quant Healthcare Fund Regular Growth 265

    Suven Life Sciences FAQs

    What is Share Price of Suven Life Sciences ?

    Suven Life Sciences share price is ₹100 As on 13 May, 2024 | 02:52

    What is the Market Cap of Suven Life Sciences ?

    The Market Cap of Suven Life Sciences is ₹2198.2 Cr As on 13 May, 2024 | 02:52

    What is the P/E ratio of Suven Life Sciences ?

    The P/E ratio of Suven Life Sciences is -20.9 As on 13 May, 2024 | 02:52

    What is the PB ratio of Suven Life Sciences ?

    The PB ratio of Suven Life Sciences is 8.1 As on 13 May, 2024 | 02:52

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.